{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:48:32Z","timestamp":1742914112730,"version":"3.40.3"},"publisher-location":"Cham","reference-count":94,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030926151"},{"type":"electronic","value":"9783030926168"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-92616-8_15","type":"book-chapter","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:02:41Z","timestamp":1647241361000},"page":"383-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Immunogenetics of Melanoma"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-9004","authenticated-orcid":false,"given":"Farzaneh","family":"Darbeheshti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1046\/j.1523-1747.1999.00772.x","volume":"113","author":"P Alard","year":"1999","unstructured":"Alard P, Niizeki H, Hanninen L, Streilein JW (1999) Local ultraviolet B irradiation impairs contact hypersensitivity induction by triggering release of tumor necrosis factor-\u03b1 from mast cells. Involvement of mast cells and Langerhans cells in susceptibility to ultraviolet B. J Investig Dermatol 113:983\u2013990","journal-title":"J Investig Dermatol"},{"key":"15_CR2","doi-asserted-by":"crossref","unstructured":"Allard M, Oger R, Vignard V, Percier J-M, Fregni G, P\u00e9rier A, Caignard A, Charreau B, Bernardeau K, Khammari A (2011) Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer. PLoS One 6:e21118","DOI":"10.1371\/journal.pone.0021118"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00008390-200502000-00009","volume":"15","author":"R Alonso","year":"2005","unstructured":"Alonso R, Suarez A, Castro P, Lacave AJ, Gutierrez C (2005) Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease. Melanoma Res 15:53\u201360","journal-title":"Melanoma Res"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1039\/c7pp00411g","volume":"17","author":"E Anne","year":"2018","unstructured":"Anne E (2018) Melanoma\u2013role of the environment and genetics. Photochem Photobiol Sci 17:1853\u20131860","journal-title":"Photochem Photobiol Sci"},{"key":"15_CR5","doi-asserted-by":"crossref","unstructured":"Arisi M, Zane C, Caravello S, Rovati C, Zanca A, Venturini M, Calzavara-Pinton P (2018) Sun exposure and melanoma, certainties and weaknesses of the present knowledge. Front Med 5","DOI":"10.3389\/fmed.2018.00235"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1399-0039.1998.tb03025.x","volume":"52","author":"A Bateman","year":"1998","unstructured":"Bateman A, Turner S, Theaker J, Howell W (1998) HLA-DQB1* 0303 and* 0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population. Tissue Antigens 52:67\u201373","journal-title":"Tissue Antigens"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1084\/jem.20091725","volume":"207","author":"L Biggs","year":"2010","unstructured":"Biggs L, Yu C, Fedoric B, Lopez AF, Galli SJ, Grimbaldeston MA (2010) Evidence that vitamin D3 promotes mast cell\u2013dependent reduction of chronic UVB-induced skin pathology in mice. J Exp Med 207:455\u2013463","journal-title":"J Exp Med"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrc3246","volume":"12","author":"T Blankenstein","year":"2012","unstructured":"Blankenstein T, Coulie PG, Gilboa E, Jaffee EM (2012) The determinants of tumour immunogenicity. Nat Rev Cancer 12:307","journal-title":"Nat Rev Cancer"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00262-009-0751-2","volume":"59","author":"MG Bouwhuis","year":"2010","unstructured":"Bouwhuis MG, Gast A, Figl A, Eggermont AM, Hemminki K, Schadendorf D, Kumar R (2010) Polymorphisms in the CD28\/CTLA4\/ICOS genes: role in malignant melanoma susceptibility and prognosis? Cancer Immunol Immunother 59:303","journal-title":"Cancer Immunol Immunother"},{"key":"15_CR10","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68:394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"15_CR11","first-page":"6997","volume":"62","author":"MS Brose","year":"2002","unstructured":"Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A (2002) BRAF and RAS mutations in human lung cancer and melanoma. Can Res 62:6997\u20137000","journal-title":"Can Res"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1039\/c4pp00399c","volume":"14","author":"SN Byrne","year":"2015","unstructured":"Byrne SN, Hammond KJ, Chan CY-Y, Rogers LJ, Beaugie C, Rana S, Marsh-Wakefield F, Thurman JM, Halliday GM (2015) The alternative complement component factor B regulates UV-induced oedema, systemic suppression of contact and delayed hypersensitivity, and mast cell infiltration into the skin. Photochem Photobiol Sci 14:801\u2013806","journal-title":"Photochem Photobiol Sci"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00251-008-0303-5","volume":"60","author":"R Carretero","year":"2008","unstructured":"Carretero R, Romero JM, Ruiz-Cabello F, Maleno I, Rodriguez F, Camacho FM, Real LM, Garrido F, Cabrera T (2008) Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy. Immunogenetics 60:439","journal-title":"Immunogenetics"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ijc.26471","volume":"131","author":"R Carretero","year":"2012","unstructured":"Carretero R, Wang E, Rodriguez AI, Reinboth J, Ascierto ML, Engle AM, Liu H, Camacho FM, Marincola FM, Garrido F (2012) Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes. Int J Cancer 131:387\u2013395","journal-title":"Int J Cancer"},{"key":"15_CR15","doi-asserted-by":"crossref","unstructured":"Chat V, Ferguson R, Simpson D, Kazlow E, Lax R, Moran U, Pavlick A, Frederick D, Boland G, Sullivan R (2019) Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition. Cancer Immunol Immunoth1\u20139","DOI":"10.1007\/s00262-019-02318-8"},{"key":"15_CR16","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Rodger EJ, Ahn A, Stockwell PA, Parry M, Motwani J, Gallagher SJ, Shklovskaya E, Tiffen J, Eccles MR (2018) Marked global DNA hypomethylation is associated with constitutive PD-L1 expression in melanoma. iScience 4:312\u2013325","DOI":"10.1016\/j.isci.2018.05.021"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1600-0781.1995.tb00149.x","volume":"11","author":"E Corsini","year":"1995","unstructured":"Corsini E, Bruccoleri A, Marinovich M, Galli C (1995) In vitro mechanism (s) of ultraviolet-induced tumor necrosis factor-\u03b1 release in a human keratinocyte cell line. Photodermatol Photoimmunol Photomed 11:112\u2013118","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"15_CR18","doi-asserted-by":"crossref","unstructured":"da Silva WC, Oshiro TM, de S\u00e1 DC, Franco DD, Neto CF, Pontillo A (2016) Genotyping and differential expression analysis of inflammasome genes in sporadic malignant melanoma reveal novel contribution of CARD8, IL1B and IL18 in melanoma susceptibility and progression. Cancer genetics 209:474\u2013480","DOI":"10.1016\/j.cancergen.2016.09.004"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1038\/jid.2015.336","volume":"135","author":"E Damiani","year":"2015","unstructured":"Damiani E, Puebla-Osorio N, Gorbea E, Ullrich SE (2015) Platelet-activating factor induces epigenetic modifications in human mast cells. J Investig Dermatol 135:3034\u20133040","journal-title":"J Investig Dermatol"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"E7769","DOI":"10.1073\/pnas.1607836113","volume":"113","author":"L Danilova","year":"2016","unstructured":"Danilova L, Wang H, Sunshine J, Kaunitz GJ, Cottrell TR, Xu H, Esandrio J, Anders RA, Cope L, Pardoll DM (2016) Association of PD-1\/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors. Proc Natl Acad Sci 113:E7769\u2013E7777","journal-title":"Proc Natl Acad Sci"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis BK, Wen H, Ting JP-Y (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29:707\u2013735","journal-title":"Annu Rev Immunol"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/sj.onc.1210912","volume":"27","author":"E El-Omar","year":"2008","unstructured":"El-Omar E, Ng M, Hold G (2008) Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 27:244","journal-title":"Oncogene"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/ol.2016.4584","volume":"12","author":"L Elefanti","year":"2016","unstructured":"Elefanti L, Sacco G, Stagni C, Rastrelli M, Menin C, Russo I, Alaibac M (2016) TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma. Oncol Lett 12:275\u2013280","journal-title":"Oncol Lett"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3835(96)04213-9","volume":"104","author":"C Fortis","year":"1996","unstructured":"Fortis C, Foppoli M, Gianotti L, Galli L, Citterio G, Consogno G, Gentilini O, Braga M (1996) Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett 104:1\u20135","journal-title":"Cancer Lett"},{"key":"15_CR25","doi-asserted-by":"crossref","unstructured":"Gast A, Bermejo JL, Claus R, Brandt A, Weires M, Weber A, Plass C, Sucker A, Hemminki K, Schadendorf D (2011) Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. PLoS One 6:e24370.","DOI":"10.1371\/journal.pone.0024370"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa053007","volume":"354","author":"H Gogas","year":"2006","unstructured":"Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, Panagiotou P, Polyzos A, Papadopoulos O, Stratigos A (2006) Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354:709\u2013718","journal-title":"N Engl J Med"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1158\/1535-7163.MCT-08-0582","volume":"7","author":"Y Goto","year":"2008","unstructured":"Goto Y, Arigami T, Kitago M, Nguyen SL, Narita N, Ferrone S, Morton DL, Irie RF, Hoon DS (2008) Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther 7:3642\u20133653","journal-title":"Mol Cancer Ther"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2133.2004.05966.x","volume":"150","author":"M Grimbaldeston","year":"2004","unstructured":"Grimbaldeston M, Pearce A, Robertson B, Coventry B, Marshman G, Finlay-Jones J, Hart P (2004) Association between melanoma and dermal mast cell prevalence in sun-unexposed skin. Br J Dermatol 150:895\u2013903","journal-title":"Br J Dermatol"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1562\/0031-8655(2003)078<0633:STBCCI>2.0.CO;2","volume":"78","author":"MA Grimbaldeston","year":"2003","unstructured":"Grimbaldeston MA, Green A, Darlington S, Robertson BO, Marshman G, Finlay-Jones JJ, Hart PH (2003) Susceptibility to basal cell carcinoma is associated with high dermal mast cell prevalence in non\u2013sun-exposed skin for an Australian population. Photochem Photobiol 78:633\u2013639","journal-title":"Photochem Photobiol"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-065X.2011.01046.x","volume":"243","author":"O Gross","year":"2011","unstructured":"Gross O, Thomas CJ, Guarda G, Tschopp J (2011) The inflammasome: an integrated view. Immunol Rev 243:136\u2013151","journal-title":"Immunol Rev"},{"key":"15_CR31","doi-asserted-by":"crossref","unstructured":"Halk A, Potjer T, Kukutsch N, Vasen H, Hes F, van Doorn R (2019) Surveillance for familial melanoma: recommendations from a national centre of expertise. Br J Dermatol","DOI":"10.1111\/bjd.17767"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fimmu.2019.00251","volume":"10","author":"P Han","year":"2019","unstructured":"Han P, Dai Q, Fan L, Zhang X, Li F, Yang X (2019) Genome-wide CRISPR screening identifies JAK1 deficiency as a mechanism of T-cell resistance. Front Immunol 10:251","journal-title":"Front Immunol"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1039\/c7pp00312a","volume":"17","author":"PH Hart","year":"2018","unstructured":"Hart PH, Norval M (2018) Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis. Photochem Photobiol Sci 17:1872\u20131884","journal-title":"Photochem Photobiol Sci"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-genom-091212-153429","volume":"14","author":"VK Hill","year":"2013","unstructured":"Hill VK, Gartner JJ, Samuels Y, Goldstein AM (2013) The genetics of melanoma: recent advances. Annu Rev Genomics Hum Genet 14:257\u2013279","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"15_CR35","doi-asserted-by":"crossref","unstructured":"Hino R, Kabashima K, Kato Y, Yagi H, Nakamura M, Honjo T, Okazaki T, Tokura Y (2010) Tumor cell expression of programmed cell death\u20101 ligand 1 is a prognostic factor for malignant melanoma. Cancer: Interdiscip Int J Am Cancer Soc 116:1757\u20131766","DOI":"10.1002\/cncr.24899"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/sj.gene.6363726","volume":"2","author":"W Howell","year":"2001","unstructured":"Howell W, Turner S, Bateman A, Theaker J (2001) IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun 2:25","journal-title":"Genes Immun"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ijc.11456","volume":"108","author":"EC Ibrahim","year":"2004","unstructured":"Ibrahim EC, Aractingi S, Allory Y, Borrini F, Dupuy A, Duvillard P, Carosella ED, Avril MF, Paul P (2004) Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype. Int J Cancer 108:243\u2013250","journal-title":"Int J Cancer"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/modpathol.2011.5","volume":"24","author":"E Itakura","year":"2011","unstructured":"Itakura E, Huang R-R, Wen D-R, Paul E, W\u00fcnsch PH, Cochran AJ (2011) IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. Mod Pathol 24:801","journal-title":"Mod Pathol"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ygeno.2016.04.005","volume":"107","author":"Y Jiang","year":"2016","unstructured":"Jiang Y, Shi X, Zhao Q, Krauthammer M, Rothberg BEG, Ma S (2016) Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis. Genomics 107:223\u2013230","journal-title":"Genomics"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"9717","DOI":"10.1073\/pnas.88.21.9717","volume":"88","author":"CV Jongeneel","year":"1991","unstructured":"Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A (1991) Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci 88:9717\u20139721","journal-title":"Proc Natl Acad Sci"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1399-0039.1997.tb02780.x","volume":"49","author":"T Kageshila","year":"1997","unstructured":"Kageshila T, Naruse T, Hiral S, Ono T, Horikoshi T, Nakagawa H, Tamaki K, Hayashibe K, Ichihashi M, Nakayama J (1997) Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma. Tissue Antigens 49:466\u2013470","journal-title":"Tissue Antigens"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00005-016-0437-3","volume":"64","author":"SM Kandilarova","year":"2016","unstructured":"Kandilarova SM, Paschen A, Mihaylova A, Ivanova M, Schadendorf D, Naumova E (2016) The influence of HLA and KIR genes on malignant melanoma development and progression. Arch Immunol Ther Exp 64:73\u201381","journal-title":"Arch Immunol Ther Exp"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","volume":"162","author":"S Kleffel","year":"2015","unstructured":"Kleffel S, Posch C, Barthel SR, Mueller H, Schlapbach C, Guenova E, Elco CP, Lee N, Juneja VR, Zhan Q (2015) Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth. Cell 162:1242\u20131256","journal-title":"Cell"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajhg.2009.07.012","volume":"85","author":"DC Ko","year":"2009","unstructured":"Ko DC, Shukla KP, Fong C, Wasnick M, Brittnacher MJ, Wurfel MM, Holden TD, O\u2019Keefe GE, Van Yserloo B, Akey JM (2009) A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease. Am J Human Genet 85:214\u2013227","journal-title":"Am J Human Genet"},{"key":"15_CR45","doi-asserted-by":"crossref","unstructured":"Kochan G, Escors D, Breckpot K, Guerrero-Setas D (2013) Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology 2:e26491","DOI":"10.4161\/onci.26491"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1084\/jem.172.6.1609","volume":"172","author":"A K\u00f6ck","year":"1990","unstructured":"K\u00f6ck A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel J, Luger T (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609\u20131614","journal-title":"J Exp Med"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","volume":"388","author":"H Kumar","year":"2009","unstructured":"Kumar H, Kawai T, Akira S (2009) Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388:621\u2013625","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR48","doi-asserted-by":"crossref","unstructured":"Lenci RE, Bevier M, Brandt A, Bermejo JL, Sucker A, Moll I, Planelles D, Requena C, Nagore E, Hemminki K (2012) Influence of genetic variants in type I interferon genes on melanoma survival and therapy. PLoS One 7:e50692","DOI":"10.1371\/journal.pone.0050692"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.abb.2011.01.005","volume":"508","author":"W Lewis","year":"2011","unstructured":"Lewis W, Simanyi E, Li H, Thompson CA, Nasti TH, Jaleel T, Xu H, Yusuf N (2011) Regulation of ultraviolet radiation induced cutaneous photoimmunosuppression by toll-like receptor-4. Arch Biochem Biophys 508:171\u2013177","journal-title":"Arch Biochem Biophys"},{"key":"15_CR50","doi-asserted-by":"crossref","unstructured":"Liu-Smith F, Jia J, Zheng Y (2017) UV-induced molecular signaling differences in melanoma and non-melanoma skin cancer. In: Ultraviolet light in human health, diseases and environment. Springer, pp 27\u201340","DOI":"10.1007\/978-3-319-56017-5_3"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10549-010-0910-3","volume":"124","author":"X Liu","year":"2010","unstructured":"Liu X, Wang Z, Yu J, Lei G, Wang S (2010) Three polymorphisms in interleukin-1\u03b2 gene and risk for breast cancer: a meta-analysis. Breast Cancer Res Treat 124:821\u2013825","journal-title":"Breast Cancer Res Treat"},{"key":"15_CR52","doi-asserted-by":"crossref","unstructured":"Lombardi ML, Mercuro O, Pirozzi G, Ionna F, Lombari V, Mozzillo N, Manzo C (1998) Molecular analysis of HLA DRB1 and DQB1 polymorphism in Italian melanoma patients. J Immunother (Hagerstown, Md.: 1997) 21:435\u2013439","DOI":"10.1097\/00002371-199811000-00005"},{"key":"15_CR53","doi-asserted-by":"crossref","unstructured":"Lukens JR, Kanneganti T-D (2014) Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease. In: Seminars in immunopathology. Springer, pp 595\u2013609","DOI":"10.1007\/s00281-014-0434-8"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1399-0039.1998.tb03102.x","volume":"51","author":"P Lulli","year":"1998","unstructured":"Lulli P, Grammatico P, Brioli G, Catricala C, Morellini M, Roccella M, Mariani B, Pennesi G, Roccella F, Cappellacci S (1998) HLA-DR and-DQ alleles in Italian patients with melanoma. Tissue Antigens 51:276\u2013280","journal-title":"Tissue Antigens"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/gast.2001.28000","volume":"121","author":"JC Machado","year":"2001","unstructured":"Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F (2001) Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121:823\u2013829","journal-title":"Gastroenterology"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00002371-199511000-00005","volume":"18","author":"FM Marincola","year":"1995","unstructured":"Marincola FM, Shamamian P, Rivoltini L, Salgaller M, Cormier J, Restifo NP, Simonis TB, Venzon D, White DE, Parkinson DR (1995) HLA associations in the antitumor response against malignant melanoma. J Immunother Emphas Tumor Immunol: Off J Soc Biol Ther 18:242","journal-title":"J Immunother Emphas Tumor Immunol: Off J Soc Biol Ther"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00008390-200209000-00008","volume":"12","author":"J Martinez-Escribano","year":"2002","unstructured":"Martinez-Escribano J, Moya-Quiles M, Muro M, Montes-Ares O, Hernandez-Caselles T, Frias J, Alvarez-Lopez M (2002) Interleukin-10, interleukin-6 and interferon-\u03b3 gene polymorphisms in melanoma patients. Melanoma Res 12:465\u2013469","journal-title":"Melanoma Res"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.clim.2017.09.004","volume":"183","author":"WN Melsted","year":"2017","unstructured":"Melsted WN, Johansen LL, Lock-Andersen J, Behrendt N, Eriksen JO, Bzorek M, Scheike T, Hviid TVF (2017) HLA class Ia and Ib molecules and FOXP3+ TILs in relation to the prognosis of malignant melanoma patients. Clin Immunol 183:191\u2013197","journal-title":"Clin Immunol"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1751-1097.2012.01182.x","volume":"88","author":"TH Nasti","year":"2012","unstructured":"Nasti TH, Timares L (2012) Inflammasome activation of IL-1 family mediators in response to cutaneous photodamage. Photochem Photobiol 88:1111\u20131125","journal-title":"Photochem Photobiol"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1046-2023(02)00211-6","volume":"28","author":"H Niizeki","year":"2002","unstructured":"Niizeki H, Inoko H, Streilein JW (2002) Polymorphisms in the TNF region confer susceptibility to UVB-induced impairment of contact hypersensitivity induction in mice and humans. Methods 28:46\u201354","journal-title":"Methods"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1034\/j.1399-0039.2001.580605.x","volume":"58","author":"H Niizeki","year":"2001","unstructured":"Niizeki H, Naruse T, Hecker K, Taylor J, Kurimoto I, Shimizu T, Yamasaki Y, Inoko H, Streilein J (2001) Polymorphisms in the tumor necrosis factor (TNF) genes are associated with susceptibility to effects of ultraviolet-B radiation on induction of contact hypersensitivity. Tissue Antigens 58:369\u2013378","journal-title":"Tissue Antigens"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/1055-9965.EPI-12-1129","volume":"22","author":"JY Park","year":"2013","unstructured":"Park JY, Amankwah EK, Anic GM, Lin H-Y, Walls B, Park H, Krebs K, Madden M, Maddox K, Marzban S (2013) Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Prev Biomark 22:827\u2013834","journal-title":"Cancer Epidemiol Prev Biomark"},{"key":"15_CR64","doi-asserted-by":"crossref","unstructured":"Passarelli A, Mannavola F, Stucci LS, Tucci M, Silvestris F (2017) Immune system and melanoma biology: a balance between immunosurveillance and immune escape. Oncotarget 8:106132.","DOI":"10.18632\/oncotarget.22190"},{"key":"15_CR65","first-page":"1954","volume":"59","author":"P Paul","year":"1999","unstructured":"Paul P, Cabestr\u00e9 FA, Le Gal F-A, Khalil-Daher I, Le Danff C, Schmid M, Mercier S, Avril M-F, Dausset J, Guillet J-G (1999) Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Can Res 59:1954\u20131960","journal-title":"Can Res"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","volume":"95","author":"P Paul","year":"1998","unstructured":"Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci 95:4510\u20134515","journal-title":"Proc Natl Acad Sci"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0966-3274(98)80045-2","volume":"6","author":"C Perrey","year":"1998","unstructured":"Perrey C, Pravica V, Sinnott PJ, Hutchinson IV (1998) Genotyping for polymorphisms in interferon-\u03b3, interleukin-10, transforming growth factor-\u03b21 and tumour necrosis factor-\u03b1 genes: a technical report. Transpl Immunol 6:193\u2013197","journal-title":"Transpl Immunol"},{"key":"15_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2133.2005.06896.x","volume":"154","author":"D Planelles","year":"2006","unstructured":"Planelles D, Nagore E, Moret A, Botella-Estrada R, Vila E, Guill\u00e9n C, Montoro J (2006) HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor. Br J Dermatol 154:261\u2013266","journal-title":"Br J Dermatol"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","volume":"33","author":"MA Postow","year":"2015","unstructured":"Postow MA, Callahan MK, Wolchok JD (2015) Immune checkpoint blockade in cancer therapy. J Clin Oncol 33:1974","journal-title":"J Clin Oncol"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3109\/07357907.2013.793699","volume":"31","author":"P Queirolo","year":"2013","unstructured":"Queirolo P, Morabito A, Laurent S, Lastraioli S, Piccioli P, Ascierto P, Gentilcore G, Serra M, Marasco A, Tornari E (2013) Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study. Cancer Invest 31:336\u2013345","journal-title":"Cancer Invest"},{"key":"15_CR71","doi-asserted-by":"crossref","unstructured":"Rebmann V, Wagner S, Grosse-Wilde H (2007) HLA-G expression in malignant melanoma. In: Seminars in cancer biology. Elsevier, pp 422\u2013429","DOI":"10.1016\/j.semcancer.2007.06.010"},{"key":"15_CR72","doi-asserted-by":"crossref","unstructured":"Rendleman J, Shang S, Shields J, Adaniel C, Fleming NH, Shapiro R, Berman RS, Pavlick AC, Shao Y, Osman I (2013) Genetic variation in immunomodulatory genes as markers of melanoma recurrence-free and overall survival. American Society of Clinical Oncology, City","DOI":"10.1200\/jco.2013.31.15_suppl.9021"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/jmedgenet-2014-102832","volume":"52","author":"J Rendleman","year":"2015","unstructured":"Rendleman J, Vogelsang M, Bapodra A, Adaniel C, Silva I, Moogk D, Martinez CN, Fleming N, Shields J, Shapiro R (2015) Genetic associations of the interleukin locus at 1q32. 1 with clinical outcomes of cutaneous melanoma. J Med Genet 52:231\u2013239","journal-title":"J Med Genet"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2016.4059","volume":"315","author":"A Ribas","year":"2016","unstructured":"Ribas A, Hamid O, Daud A, Hodi FS, Wolchok JD, Kefford R, Joshua AM, Patnaik A, Hwu W-J, Weber JS (2016) Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA 315:1600\u20131609","journal-title":"JAMA"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/jid.2013.424","volume":"134","author":"SN Sarchio","year":"2014","unstructured":"Sarchio SN, Scolyer RA, Beaugie C, McDonald D, Marsh-Wakefield F, Halliday GM, Byrne SN (2014) Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer. J Investig Dermatol 134:1091\u20131100","journal-title":"J Investig Dermatol"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1080\/21645515.2015.1129478","volume":"12","author":"P Savoia","year":"2016","unstructured":"Savoia P, Astrua C, Fava P (2016) Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: effectiveness and toxicity management. Hum Vaccin Immunother 12:1092\u20131101","journal-title":"Hum Vaccin Immunother"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi AC, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S (2018) Melanoma. The Lancet 392:971\u2013984","journal-title":"The Lancet"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2133.2007.08316.x","volume":"158","author":"M Singh","year":"2008","unstructured":"Singh M, Lin J, Hocker T, Tsao H (2008) Genetics of melanoma tumorigenesis. Br J Dermatol 158:15\u201321","journal-title":"Br J Dermatol"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.4049\/jimmunol.170.6.3423","volume":"170","author":"A Sleijffers","year":"2003","unstructured":"Sleijffers A, Yucesoy B, Kashon M, Garssen J, De Gruijl FR, Boland GJ, Van Hattum J, Luster MI, Van Loveren H (2003) Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J Immunol 170:3423\u20133428","journal-title":"J Immunol"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/eji.201445289","volume":"46","author":"R Sottile","year":"2016","unstructured":"Sottile R, Pangigadde PN, Tan T, Anichini A, Sabbatino F, Trecroci F, Favoino E, Orgiano L, Roberts J, Ferrone S (2016) HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors. Eur J Immunol 46:409\u2013419","journal-title":"Eur J Immunol"},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/jid.1994.19","volume":"103","author":"JW Streilein","year":"1994","unstructured":"Streilein JW, Taylor JR, Vincek V, Kurimoto I, Richardson J, Tie C, Medema J-P, Golomb C (1994) Relationship between ultraviolet radiation-induced immunosuppression and carcinogenesis. J Investig Dermatol 103:107\u2013111","journal-title":"J Investig Dermatol"},{"key":"15_CR82","doi-asserted-by":"crossref","unstructured":"Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, Chen S, Klein AP, Pardoll DM, Topalian SL (2012) Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 4:127ra137\u2013127ra137","DOI":"10.1126\/scitranslmed.3003689"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1158\/1078-0432.CCR-11-0230","volume":"17","author":"EP Tjin","year":"2011","unstructured":"Tjin EP, Konijnenberg D, Krebbers G, Mallo H, Drijfhout JW, Franken KL, van der Horst CM, Bos JD, Nieweg OE, Kroon BB (2011) T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Clin Cancer Res 17:5736\u20135747","journal-title":"Clin Cancer Res"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/pcmr.12164","volume":"27","author":"E Tremante","year":"2014","unstructured":"Tremante E, Ginebri A, Lo Monaco E, Benassi B, Frascione P, Grammatico P, Cappellacci S, Catrical\u00e0 C, Arcelli D, Natali PG (2014) A melanoma immune response signature including Human Leukocyte Antigen-E. Pigment Cell Melanoma Res 27:103\u2013112","journal-title":"Pigment Cell Melanoma Res"},{"key":"15_CR85","doi-asserted-by":"crossref","unstructured":"Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse\u2010Wilde H, Reinhold U (2001) Soluble human leukocyte antigen\u2013G serum level is elevated in melanoma patients and is further increased by interferon\u2010\u03b1 immunotherapy. Cancer: Interdiscipl Int J Am Cancer Soc 92:369\u2013376.","DOI":"10.1002\/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejca.2015.09.013","volume":"53","author":"S Ugurel","year":"2016","unstructured":"Ugurel S, R\u00f6hmel J, Ascierto PA, Flaherty KT, Grob JJ, Hauschild A, Larkin J, Long GV, Lorigan P, McArthur GA (2016) Survival of patients with advanced metastatic melanoma: the impact of novel therapies. Eur J Cancer 53:125\u2013134","journal-title":"Eur J Cancer"},{"key":"15_CR87","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1755-148X.2012.01008.x","volume":"25","author":"D Verma","year":"2012","unstructured":"Verma D, Bivik C, Farahani E, Synnerstad I, Fredrikson M, Enerb\u00e4ck C, Rosdahl I, S\u00f6derkvist P (2012) Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res 25:506\u2013513","journal-title":"Pigment Cell Melanoma Res"},{"key":"15_CR88","first-page":"258","volume":"7","author":"M Vermeer","year":"1990","unstructured":"Vermeer M, Streilein J (1990) Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed 7:258\u2013265","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"15_CR89","first-page":"728","volume":"53","author":"V Vincek","year":"1993","unstructured":"Vincek V, Kurimoto I, Medema JP, Prieto E, Streilein JW (1993) Tumor necrosis factor \u03b1 polymorphism correlates with deleterious effects of ultraviolet B light on cutaneous immunity. Can Res 53:728\u2013732","journal-title":"Can Res"},{"key":"15_CR90","doi-asserted-by":"crossref","unstructured":"von Euw EM, Barrio MM, Furman D, Levy EM, Bianchini M, Peguillet I, Lantz O, Vellice A, Kohan A, Chac\u00f3n M (2008) A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic\/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10-1082 promoter genotype as predictor of disease progression. J Trans Med 6:6","DOI":"10.1186\/1479-5876-6-6"},{"key":"15_CR91","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","volume":"16","author":"JS Weber","year":"2015","unstructured":"Weber JS, D\u2019Angelo SP, Minor D, Hodi FS, Gutzmer R, Neyns B, Hoeller C, Khushalani NI, Miller WH Jr, Lao CD (2015) Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 16:375\u2013384","journal-title":"Lancet Oncol"},{"key":"15_CR92","doi-asserted-by":"publisher","first-page":"8706","DOI":"10.1158\/0008-5472.CAN-04-4649","volume":"65","author":"M Yamamoto","year":"2005","unstructured":"Yamamoto M, Torigoe T, Kamiguchi K, Hirohashi Y, Nakanishi K, Nabeta C, Asanuma H, Tsuruma T, Sato T, Hata F (2005) A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8\u2013and caspase-9\u2013mediated apoptosis. Can Res 65:8706\u20138714","journal-title":"Can Res"},{"key":"15_CR93","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF00241633","volume":"32","author":"T Yoshikawa","year":"1990","unstructured":"Yoshikawa T, Streilein JW (1990) Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility. Immunogenetics 32:398\u2013405","journal-title":"Immunogenetics"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1038\/onc.2017.26","volume":"36","author":"Z Zhai","year":"2017","unstructured":"Zhai Z, Liu W, Kaur M, Luo Y, Domenico J, Samson JM, Shellman YG, Norris DA, Dinarello CA, Spritz RA (2017) NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene 36:3820","journal-title":"Oncogene"}],"container-title":["Advances in Experimental Medicine and Biology","The Immunogenetics of Dermatologic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-92616-8_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T10:30:54Z","timestamp":1668162654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-92616-8_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030926151","9783030926168"],"references-count":94,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-92616-8_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 March 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}